Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T21:53:28.393Z.
Calculation as of: 2026-10-06T21:53:28.393Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fe2709ba5bee8827173e7eb2406bfc0a2a715a78b0d2155f196b4173acd92065
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2021-11-12.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$471.57M
EV/EBITDA Ratio
8036.17x
TTM Avg
8683.24x
3Y Avg
8683.24x
5Y Avg
8683.24x
Market Cap
$472.23M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$475.91M
EV/EBITDA Ratio
N/A
TTM Avg
5.88x
3Y Avg
17.52x
5Y Avg
17.52x
Market Cap
$483.54M
EV/EBITDA Ratio
10.41x
TTM Avg
7.79x
3Y Avg
5.90x
5Y Avg
5.85x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | $469.12M | N/A | N/A | N/A | N/A |
| Kamada Ltd. (KMDA)vs › | $467.90M | 10.44x | 9.91x | 9.78x | 16.95x |
| Cerus Corporation (CERS)vs › | $471.57M | 8036.17x | 8683.24x | 8683.24x | 8683.24x |
| Arvinas, Inc. (ARVN)vs › | $471.65M | N/A | N/A | N/A | N/A |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.23M | N/A | N/A | N/A | N/A |
| Sight Sciences, Inc. (SGHT)vs › | $465.75M | N/A | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $475.91M | N/A | 5.88x | 17.52x | 17.52x |
| Puma Biotechnology, Inc. (PBYI)vs › | $483.54M | 10.41x | 7.79x | 5.90x | 5.85x |
| NRC Health (NRC)vs › | $452.54M | 23.08x | 16.39x | 15.03x | 16.69x |
| Evolus, Inc. (EOLS)vs › | $486.01M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2021-11-12 | 300.39x |
| 2021-11-11 | 280.27x |
| 2021-11-10 | 234.38x |
| 2021-11-09 | 255.68x |
| 2021-11-08 | 258.31x |
| 2021-11-05 | 259.36x |
| 2021-11-04 | 256.60x |
| 2021-11-03 | 255.02x |
| 2021-11-02 | 255.28x |
| 2021-11-01 | 255.68x |
| 2021-10-29 | 255.55x |
| 2021-10-28 | 255.68x |
| 2021-10-27 | 252.52x |
| 2021-10-26 | 259.23x |
| 2021-10-25 | 266.99x |
| 2021-10-22 | 265.80x |
| 2021-10-21 | 264.62x |
| 2021-10-20 | 266.99x |
| 2021-10-19 | 265.01x |
| 2021-10-18 | 238.32x |
| 2021-10-15 | 256.99x |
| 2021-10-14 | 273.43x |
| 2021-10-13 | 295.65x |
| 2021-10-12 | 295.13x |
| 2021-10-11 | 274.09x |
| 2021-10-08 | 282.90x |
| 2021-10-07 | 296.84x |
| 2021-10-06 | 239.37x |
| 2021-10-05 | 275.40x |
| 2021-10-04 | 280.92x |
| 2021-10-01 | 304.59x |
| 2021-09-30 | 280.53x |
| 2021-09-29 | 277.77x |
| 2021-09-28 | 282.77x |
| 2021-09-27 | 280.40x |
| 2021-09-24 | 255.55x |
| 2021-09-23 | 257.39x |
| 2021-09-22 | 265.54x |
| 2021-09-21 | 277.77x |
| 2021-09-20 | 266.85x |
| 2021-09-17 | 276.72x |
| 2021-09-16 | 289.08x |
| 2021-09-15 | 314.72x |
| 2021-09-14 | 291.97x |
| 2021-09-13 | 279.48x |
| 2021-09-10 | 253.44x |
| 2021-09-09 | 246.74x |
| 2021-09-08 | 246.87x |
| 2021-09-07 | 225.30x |
| 2021-09-03 | 202.82x |
| 2021-09-02 | 190.06x |
| 2021-09-01 | 197.29x |
| 2021-08-31 | 203.21x |
| 2021-08-30 | 203.08x |
| 2021-08-27 | 203.08x |
| 2021-08-26 | 197.82x |
| 2021-08-25 | 191.24x |
| 2021-08-24 | 205.31x |
| 2021-08-23 | 212.81x |
| 2021-08-20 | 202.42x |
| 2021-08-19 | 210.44x |
| 2021-08-18 | 209.26x |
| 2021-08-17 | 208.60x |
| 2021-08-16 | 226.62x |
| 2021-08-13 | 99.25x |
| 2021-08-12 | 100.49x |
| 2021-08-11 | 101.98x |
| 2021-08-10 | 108.99x |
| 2021-08-09 | 108.84x |
| 2021-08-06 | 110.33x |
| 2021-08-05 | 109.30x |
| 2021-08-04 | 110.28x |
| 2021-08-03 | 109.97x |
| 2021-08-02 | 118.53x |
| 2021-07-30 | 113.99x |
| 2021-07-29 | 104.82x |
| 2021-07-28 | 98.22x |
| 2021-07-27 | 94.82x |
| 2021-07-26 | 89.51x |
| 2021-07-23 | 91.72x |
| 2021-07-22 | 91.88x |
| 2021-07-21 | 91.00x |
| 2021-07-20 | 90.23x |
| 2021-07-19 | 92.55x |
| 2021-07-16 | 103.42x |
| 2021-07-15 | 107.08x |
| 2021-07-14 | 113.48x |
| 2021-07-13 | 118.42x |
| 2021-07-12 | 123.17x |
| 2021-07-09 | 121.98x |
| 2021-07-08 | 115.90x |
| 2021-07-07 | 120.54x |
| 2021-07-06 | 123.17x |
| 2021-07-02 | 119.20x |
| 2021-07-01 | 125.79x |
| 2021-06-30 | 121.77x |
| 2021-06-29 | 125.79x |
| 2021-06-28 | 143.68x |
| 2021-06-25 | 128.32x |
